Suchergebnisse - "Ljørring, Christian"

PubPharm (16)

11

Defining moderate asthma exacerbations in clinical trials based on ATS/ERS joint statement

in: Respiratory medicine | 2015

von Virchow, J. | Backer, V. | de Blay, F. | +4

12

SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms

enthalten in: Annals of allergy, asthma, & immunology | 2015

von Mosbech, H. | Canonica, G. | Backer, V. | +4

13

Defining moderate asthma exacerbations in clinical trials based on ATS/ERS joint statement

enthalten in: Respiratory medicine | 2015

von Virchow, J. | Backer, V. | de Blay, F. | +4

14

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control : a randomized, double-blind, placebo-controlled trial

enthalten in: The Journal of allergy and clinical immunology | 2014

von Mosbech, H. | Deckelmann, R. | de Blay, F. | +6

15

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial

enthalten in: The journal of allergy and clinical immunology | 2014

von Mosbech, H. | Deckelmann, R. | de Blay, F. | +6

16

Predictive biomarkers of clinical efficacy of allergen-specific immunotherapy : how to proceed

enthalten in: Immunotherapy | 2013

von Shamji, M. | Ljørring, C. | Würtzen, P.